BOSCHI, STEFANO
BOSCHI, STEFANO
ARAG - AREA FINANZA E CONTABILITÀ
Personale esterno ed autonomi
Radiopharmaceutical need between the clinic and regulatory agencies: how philosophy could explain 'the road taken'
2023 Boschi, Stefano; Todde, Sergio
Optimization of Precursor Preparation in PSMA-11 Radiolabeling to Obtain a Highly Reproducible Radiochemical Yield
2022 Iudicello, Antonella; Boschi, Stefano; Ghedini, Pietro; Lohr, Frank; Panareo, Stefano
PET radiopharmacy and automation
2022 Boschi, Stefano; Todde, Sergio
Production and Quality Control of [177Lu]Lu-PSMA-I&T: Development of an Investigational Medicinal Product Dossier for Clinical Trials
2022 Di Iorio, Valentina; Boschi, Stefano; Cuni, Cristina; Monti, Manuela; Severi, Stefano; Paganelli, Giovanni; Masini, Carla
[18F]F-PSMA-1007 Radiolabelling without an On-Site Cyclotron: A Quality Issue
2021 Di Iorio, Valentina; Boschi, Stefano; Sarnelli, Anna; Cuni, Cristina; Bianchini, David; Monti, Manuela; Gorgoni, Giancarlo; Paganelli, Giovanni; Matteucci, Federica; Masini, Carla
An HPLC and UHPLC-HRMS approach to study PSMA-11 instability in aqueous solution
2021 Iudicello, Antonella; Genovese, Filippo; Di Iorio, Valentina; Cicoria, Gianfranco; Boschi, Stefano
From radiotracer to radiopharmaceutical: a philosophical approach
2021 Boschi, Stefano; Todde, Sergio
Ga-68-PSMA PET/CT for early restaging prostate cancer. Preliminary results of a prospective trial in patients with biochemical failure after radical therapy and PSA levels< 2 ng/mL
2016 francesco ceci; castellucci paolo; tiziano graziani; cristina fonti; filippo lodi; stefano boschi; stefano fanti
Synthesis and preclinical evaluation of an Al18F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand.
2016 Boschi, S; Lee, Jt; Beykan, S; Slavik, R; Wei, L; Spick, C; Eberlein, U; Buck, Ak; Lodi, F; Cicoria, G; Czernin, J; Lassmann, M; Fanti, Stefano; Herrmann, K.
11C-meta-hydroxyephedrine: a promising PET radiopharmaceutical for imaging the sympathetic nervous system.11C-meta-hydroxyephedrine: a promising PET radiopharmaceutical for imaging the sympathetic nervous system.
2015 Boschi S; Lodi F; Boschi L; Nanni C; Chondrogiannis S; Colletti PM; Rubello D; Fanti S.
Cardiac resynchronization therapy and cardiac sympathetic function.
2015 Martignani C; Diemberger I; Nanni C; Biffi M; Ziacchi M; Boschi S; Corzani A; Fanti S; Sambuceti G; Boriani G.
Heterogeneous response of cardiac sympathetic function to cardiac resynchronization therapy in heart failure documented by 11[C]-hydroxy-ephedrine and PET/CT.
2015 Capitanio S; Nanni C; Marini C; Bonfiglioli R; Martignani C; Dib B; Fuccio C; Boriani G; Picori L; Boschi S; Morbelli S; Fanti S; Sambuceti G.
(11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy.
2013 Ceci F;Castellucci P;Mamede M;SCHIAVINA R.;Rubello D;Fuccio C;Ambrosini V;Boschi S;Martorana G;Fanti S
11C-Choline PET/CT in hormonal resistant patients after radical prostatectomy
2013 Francesco Ceci, Paolo Castellucci, Riccardo Schiavina, Chiara Fuccio, Stefano Boschi, Daniele Romagnoli, Elena Tabacchi, Marcelo Mamede, Cristina Nanni, Stefano Fanti
Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results
2013 Cristina Nanni; Riccardo Schiavina; Stefano Boschi; Valentina Ambrosini; Cinzia Pettinato; Eugenio Brunocilla; Giuseppe Martorana; Stefano Fanti
Generator breakthrough and radionuclidic purification in automated synthesis of 68Ga-DOTANOC
2013 Belosi F; Cicoria G; Lodi F; Malizia C; Fanti S; Boschi S; Marengo M.
Use of 65Zn as a tracer for the assessment of purification in the 68Ga-DOTANOC synthesis.
2013 Lucconi G.; Cicoria G.; Pancaldi D.; Lodi F.; Malizia C.; Fanti S.; Boschi S.; Marengo M.
11C-Choline PET/CT in patients with biochemical relapse after radical prostatectomy and PSA levels < 0.5 ng/mL
2012 Marcelo Mamede, Paolo Castellucci, Francesco Ceci, Riccardo Schiavina, Stefano Boschi, Valentina Ambrosini, Chiara Fuccio, Annarita Ianniello, Rossella Ferrara, Stefano Fanti
Synthesis of oncological [11C]radiopharmaceuticals for clinical PET.
2012 Lodi F.; Malizia C.; Castellucci P.; Cicoria G.; Fanti S.; Boschi S.
Alveolar Rhabdomyosarcoma With Neuroendocrine Differentiation Detected by Ga-68 DOTA-NOC PET/CT: A Case Report.
2011 Zanoni L.; Lopci E.; Ambrosini V.; Boschi S.; Fanti S.